Compare Exelixis Inc. Common Stock (EXEL) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs NOV Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while NOV Inc. Common Stock trades at $18.97 (market cap $6.77B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.2× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and NOV Inc. Common Stock for 1 Days on average.
| EXEL | NOV | |
|---|---|---|
Market Cap | $14.62B | $6.77B |
Volume | 2,684,957 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $59.13 | $21.71 |
52-Week Low | $34.54 | $12.31 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $7.93B |
Dividend Yield | — | 1.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
